SEI Investments’s Atea Pharmaceuticals AVIR Stock Holding History

SEI Investments’s Portfolio AVIR Stock Details AVIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$99.2K	Hold	19,038	–	–	﹤0.01%	3185
2026 Q2	$88.5K	Sell	19,038 -137,346	-88%	-$683K	﹤0.01%	3200
2026 Q1	$841K	Buy	+156,384	New	+$718K	﹤0.01%	2436
2022 Q1	–	Sell	-54,079	Closed	-$483K	–	2578
2021 Q4	$483K	Buy	+54,079	New	+$843K	﹤0.01%	2120

Other funds holding AVIR

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

SEI Investments's AVIR Position: Q3 2026 in Review

SEI Investments held its Atea Pharmaceuticals (AVIR) position steady in Q3 2026 at 19,038 shares worth $99.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3185.

SEI Investments first reported a position in AVIR in Q4 2021 and has held it in 4 quarters since. The position peaked at $841K in Q1 2026. 89 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.

SEI Investments held 19,038 shares of Atea Pharmaceuticals worth $99.2K as of Q3 2026.
SEI Investments left its Atea Pharmaceuticals share count unchanged in Q3 2026.
Atea Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #3185 holding.
SEI Investments first reported a position in Atea Pharmaceuticals in Q4 2021 and has held it in 4 quarters since.
SEI Investments's Atea Pharmaceuticals position peaked at $841K in Q1 2026.
89 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.